Sanmedicare Pharma Private Limited
About Sanmedicare Pharma Private Limited
Data last updated:
Sanmedicare Pharma Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 10 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85191UP2014PTC065997.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shila Choudhary and Ashish Ranjan.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Behind Khetan Petrol Pump Mohaddipur Kunraghat, Gorakhpur, Uttar Pradesh, India – 273001.
As per the financials filed for FY 2019, the company reported a revenue of ₹13.36 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹8,116 (net margin 0.6%) and EBITDA of ₹8,116 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBehind Khetan Petrol Pump Mohaddipur Kunraghat, Gorakhpur, Uttar Pradesh, India – 273001
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sanmedicare Pharma Private Limited
The main business activity of Sanmedicare Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sanmedicare Pharma Private Limited FY 2021 filings available
Sanmedicare Pharma Private Limited reported revenue of ₹13.36 Lakh (up 39% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR) of Sanmedicare Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 5% over three years, including 39% growth in the latest year. EBITDA rose 163% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sanmedicare Pharma Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8,116 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8,116 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sanmedicare Pharma Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sanmedicare Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Sanmedicare Pharma Private Limited
Sanmedicare Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shila Choudhary | Director | 10 Sep 2014 | 12 Years 1 Months | Current |
| Ashish Ranjan Also directs: Seven Sages Innovations Private Limited | Director | 30 Dec 2015 | 10 Years 9 Months | Current |
| Navita Kumari Also directs: Euzoe Pharma (OPC) Private Limited | Director | 10 Sep 2014 | 12 Years 1 Months | Current |
Peer Comparison of Sanmedicare Pharma Private Limited
Sanmedicare Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Thirumoolar International Siddha Medical Research Foundation | ₹13.39 Lakh (FY 2024) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Arobel International (OPC) Private Limited | ₹13.39 Lakh (FY 2025) | •••• | •••• | -58.0% | •••• | Chavakkad, Kerala, India |
| Enlocare Chemicals Private Limited | ₹13.39 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Kasargod, Kerala, India |
| Augment Pharmaceutical Private Limited | ₹13.38 Lakh (FY 2024) | •••• | •••• | 2.0% | •••• | Japiur, Rajasthan, India |
| Saprac Pharmaceutical Private Limited | ₹13.37 Lakh (FY 2024) | •••• | •••• | •••• | Delhi, India | |
| Sanmedicare Pharma Private Limited this company | ₹13.36 Lakh (FY 2019) | •••• | •••• | 39.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Satvah Surfactants Private Limited | ₹13.36 Lakh (FY 2024) | •••• | •••• | -84.0% | •••• | Ahmedabad, Gujarat, India |
| Westmid Industries Private Limited | ₹13.35 Lakh (FY 2025) | •••• | •••• | •••• | Belda, West Bengal, India | |
| Venuschem Laboratories Private Limited | ₹13.34 Lakh (FY 2024) | •••• | •••• | 440.0% | •••• | Navi Mumbai, Maharashtra, India |
| Thampuratty's India Private Limited | ₹13.33 Lakh (FY 2022) | •••• | •••• | 262.0% | •••• | New Delhi, Delhi, India |
| Mothers Man Pharma Private Limited | ₹13.31 Lakh (FY 2022) | •••• | •••• | •••• | Cachar, Assam, India |
Peers are the five companies nearest above and the five nearest below Sanmedicare Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Sanmedicare Pharma Private Limited
Sanmedicare Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Sanmedicare Pharma Private Limited
Employment history and EPFO contributions of people linked to Sanmedicare Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sanmedicare Pharma Private Limited
Sanmedicare Pharma Private Limited has 5 board changes on record since 2014: 4 appointments and 1 cessation. The latest: Ashish Ranjan was appointed as Director on 30 Dec 2015.
Credit Ratings, Litigation & Regulatory Alerts for Sanmedicare Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sanmedicare Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sanmedicare Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sanmedicare Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sanmedicare Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanmedicare Pharma Private Limited
Sanmedicare Pharma is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 10 September 2014 (12+ years old) and is registered under CIN U85191UP2014PTC065997.
Sanmedicare Pharma reported revenue of ₹13.36 Lakh for FY 2019 (up 39% YoY).
Sanmedicare Pharma has 3 current directors:
- Shila Choudhary - Director
- Ashish Ranjan - Director
- Navita Kumari - Director
Sanmedicare Pharma reported a net profit of ₹8,116 (net margin 0.6%) and EBITDA of ₹8,116 (EBITDA margin 0.6%) for FY 2019, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sanmedicare Pharma is 5% over three years. In the latest year (FY 2019) revenue rose 39%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Sanmedicare Pharma is U85191UP2014PTC065997. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanmedicare Pharma was incorporated on 10 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Sanmedicare Pharma by revenue are Thirumoolar International Siddha Medical Research Foundation, Arobel International (OPC) Private Limited, Enlocare Chemicals Private Limited, Augment Pharmaceutical Private Limited, Saprac Pharmaceutical Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashish Ranjan was appointed as Director on 30 Dec 2015. Apoorva Choudhary ceased to be Director on 10 Jan 2015. Apoorva Choudhary was appointed as Director on 10 Sep 2014. Sanmedicare Pharma has 5 board changes on record in total.
The registered office of Sanmedicare Pharma is at Behind Khetan Petrol Pump Mohaddipur Kunraghat, Gorakhpur, Uttar Pradesh, India – 273001.
Sanmedicare Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.